CNO Financial Group (CNO)

NYSE Financials Life & Health Insurance S&P MidCap 400
$55.45
-0.98 (-1.74%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W-3.9%
1M+3.5%
3M+0.3%
6M+20.5%
YTD+30.6%
1Y+37.5%
3Y+140.5%
5Y+129.7%

Key statistics

Full financials →
Market cap$5.1B
P/E (TTM)12.7
EPS (TTM, diluted)$4.38
P/S1.11
P/B2.18
EV / EBITDA4.6
Revenue (TTM)$4.54B
Revenue growth+2.3%
Net margin9.2%
ROE18.0%
Debt / equity0.43
FCF yield14.7%
Dividend yield1.26%
Payout ratio16%
Beta (1Y)0.38
Volatility (1Y)21.1%
52-week range$38.99 – $59.15
Avg volume (50D)1.04M

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Rising Wedge (weekly)

Forming
CNO Rising Wedge chart

Trigger $53.45 (-3.6% away). Details →

Oct 29, 4:20 PM ET

CNO Financial Q3 2026 net income rises to $161 million and raises 2026 EPS guidance

Mixed earnings 2.02

CNO Financial Group reported third quarter 2026 net income of $161 million, or $1.71 per diluted share, up from $23.1 million, or $0.24, a year earlier. The company raised its full-year 2026 operating EPS guidance, with the midpoint up 9% from prior guidance. Total revenues fell to $1,086.0 million from $1,188.7 million, and $44.9 million of favorable significant items from the annual actuarial review boosted results.

  • Net operating income was $179.1 million, or $1.90 per diluted share, up 47% from $1.29 in 3Q25.
  • 2026 operating EPS guidance midpoint raised 9% from prior guidance.
  • Total revenues were $1,086.0 million, compared with $1,188.7 million in 3Q25.
  • Significant items from the comprehensive annual actuarial review added $44.9 million, or $0.48 per diluted share, to 3Q26 results.
Read the filing on SEC.gov ↗
Jul 30, 4:16 PM ET

CNO Financial raises 2026 operating EPS guidance 8% after 45% Q2 operating EPS gain

Positive earnings Written later 2.02

CNO Financial Group reported second quarter 2026 net income of $126 million, or $1.33 per diluted share, up from $91.8 million, or $0.91 per diluted share, a year earlier. The company also raised its full-year 2026 operating earnings per share guidance by 8% at the midpoint, which points to higher expected per-share earnings for shareholders.

  • Net income was $126 million, or $1.33 per diluted share, versus $91.8 million, or $0.91, in 2Q25.
  • Net operating income was $120 million, or $1.26 per diluted share, up 45% from $0.87 in 2Q25.
  • 2026 operating EPS guidance raised by 8% at the midpoint from prior guidance.
  • Repurchased $60.0 million of common stock in 2Q26; authority to repurchase up to an additional $300.4 million remained at June 30, 2026.
Read the filing on SEC.gov ↗
Apr 30, 4:21 PM ET

CNO Financial Q1 net income rises to $38 million; operating EPS up 33%

Positive earnings Written later 2.02

CNO Financial Group reported first quarter 2026 net income of $38 million, or $0.39 per diluted share, up from $21.5 million, or $0.21 per diluted share, a year earlier. Net operating income, a non-GAAP measure, was $101 million, or $1.05 per diluted share, up 33% per share, and total revenues rose to $1,029.6 million from $1,004.1 million. Shareholders also face a lower book value per share of $26.64 at March 31, 2026, compared with $27.92 at December 31, 2025.

  • Net income was $38 million ($0.39 per diluted share) in 1Q26, compared with $21.5 million ($0.21) in 1Q25.
  • Net operating income was $101 million ($1.05 per diluted share), compared with $0.79 per diluted share in 1Q25.
  • Total revenues were $1,029.6 million, compared with $1,004.1 million in 1Q25.
  • CNO repurchased $60.0 million of common stock in 1Q26 and had authority to repurchase up to an additional $360.4 million.
Read the filing on SEC.gov ↗
Feb 11, 4:17 PM ET

CNO Financial declares $0.17 dividend; director Nina Henderson to retire

Neutral shareholder Written later 5.027.01

CNO Financial Group's Board declared a $0.17 per share quarterly dividend, payable March 24, 2026. Director Nina Henderson, who joined the Board in 2012, will retire when her term ends at the May 12, 2026 annual meeting, and her decision was not based on any disagreement with the company. The Board will have nine directors after her retirement.

  • Quarterly dividend of $0.17 per common share, payable March 24, 2026, to holders of record at the close of business on March 10, 2026
  • Director Nina Henderson, who joined the Board in 2012, will retire at the conclusion of her current term at the 2026 annual meeting
  • Henderson chairs the Human Resources and Compensation Committee and is a member of the Investment Committee
  • Virtual annual meeting of shareholders on May 12, 2026, at 8:00 a.m. ET; holders of record on March 16, 2026 may vote
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own CNO

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $4.54M0.02% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All CNO congressional trades →
TradedMemberTypeAmount
Jun 11, 2025Lisa McClain MI-09Sell$1,001 – $15,000
Jun 09, 2025Lisa McClain MI-09Buy$1,001 – $15,000
May 12, 2025Jefferson Shreve IN-06Sell$15,001 – $50,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from CNO Financial Group's SEC XBRL filings. Not investment advice.